Advanced

STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement.

Gallo, Valentina; Egger, Matthias; McCormack, Valerie; Farmer, Peter B; Ioannidis, John P A; Kirsch-Volders, Micheline; Matullo, Giuseppe; Phillips, David H; Schoket, Bernadette and Strömberg, Ulf LU , et al. (2012) In European Journal of Clinical Investigation 42(1). p.1-16
Abstract
SUMMARY POINTS: Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating interactions between external and/or endogenous agents and body components or processes. The need for improved reporting of scientific research led to influential statements of recommendations such as the STrengthening Reporting of OBservational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in... (More)
SUMMARY POINTS: Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating interactions between external and/or endogenous agents and body components or processes. The need for improved reporting of scientific research led to influential statements of recommendations such as the STrengthening Reporting of OBservational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies. The present STrengthening the Reporting of OBservational studies in Epidemiology -Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE statement implementing nine existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist. The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
European Journal of Clinical Investigation
volume
42
issue
1
pages
1 - 16
publisher
Wiley-Blackwell
external identifiers
  • wos:000297738500001
  • pmid:22023344
  • scopus:83155175109
ISSN
0014-2972
DOI
10.1111/j.1365-2362.2011.02561.x
language
English
LU publication?
yes
id
75eef9c6-611a-4dca-9f7e-d07757d6d2c3 (old id 2200200)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/22023344?dopt=Abstract
date added to LUP
2011-11-02 12:51:09
date last changed
2017-11-05 03:01:54
@article{75eef9c6-611a-4dca-9f7e-d07757d6d2c3,
  abstract     = {SUMMARY POINTS: Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating interactions between external and/or endogenous agents and body components or processes. The need for improved reporting of scientific research led to influential statements of recommendations such as the STrengthening Reporting of OBservational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies. The present STrengthening the Reporting of OBservational studies in Epidemiology -Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE statement implementing nine existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist. The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations.},
  author       = {Gallo, Valentina and Egger, Matthias and McCormack, Valerie and Farmer, Peter B and Ioannidis, John P A and Kirsch-Volders, Micheline and Matullo, Giuseppe and Phillips, David H and Schoket, Bernadette and Strömberg, Ulf and Vermeulen, Roel and Wild, Christopher and Porta, Miquel and Vineis, Paolo},
  issn         = {0014-2972},
  language     = {eng},
  number       = {1},
  pages        = {1--16},
  publisher    = {Wiley-Blackwell},
  series       = {European Journal of Clinical Investigation},
  title        = {STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement.},
  url          = {http://dx.doi.org/10.1111/j.1365-2362.2011.02561.x},
  volume       = {42},
  year         = {2012},
}